Covered recipient · General Payments record
MERVAT G KELADA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,663.46
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $560.38 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $144.01 | 10 |
| Acerta Pharma LLC | $131.47 | 2 |
| Phathom Pharmaceuticals, Inc. | $125.75 | 1 |
| Astellas Pharma US Inc | $125.00 | 1 |
| Lilly USA, LLC | $34.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $125.00 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139448804 | CMS |
| AstraZeneca Pharmaceuticals LP | $5.67 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105830995 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.80 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104443847 | CMS |
| Lilly USA, LLC | $34.15 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135171542 | CMS |
| Novo Nordisk Inc | $11.93 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096844715 | CMS |
| Novo Nordisk Inc | $12.38 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097335050 | CMS |
| Novo Nordisk Inc | $10.62 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096688748 | CMS |
| Novo Nordisk Inc | $12.85 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096666332 | CMS |
| Novo Nordisk Inc | $14.67 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097413332 | CMS |
| Novo Nordisk Inc | $12.85 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097630262 | CMS |
| Novo Nordisk Inc | $15.17 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096615544 | CMS |
| Novo Nordisk Inc | $15.11 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907369 | CMS |
| Novo Nordisk Inc | $22.63 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096936981 | CMS |
| Novo Nordisk Inc | $15.80 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096890452 | CMS |
| Phathom Pharmaceuticals, Inc. | $125.75 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151080512 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.